Design challenges facing clinical trials of the effectiveness of new HIV-prevention technologies
Differential regulation of toll-like receptor pathways in acute and chronic HIV-1 infection
Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards
Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravir
Safety of task-shifting for male medical circumcision
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir
Predictors of weight loss after HAART initiation among HIV-infected adults in Tanzania
Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome
Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis
The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study
The association between Mycoplasma genitalium and HIV-1 acquisition in African women
Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing age
Another STI associated with HIV-1 acquisition
Safety and effectiveness of efavirenz versus nevirapine-based regimens in resource-limited settings
Cellular immune responses and susceptibility to HIV-1 superinfection
Low prevalence of asymptomatic sexually transmitted infections in HIV-infected heterosexuals visiting an HIV clinic in the Netherlands
Efficacy and safety of once-daily ritonavir-boosted darunavir and abacavir/lamivudine for treatment-naïve patients
Hemodiafiltration with online regeneration of ultrafiltrate for severe nevirapine intoxication in a HIV-infected patient
Super-infection with genotype 4 hepatitis C virus in a patient treated for genotype 3 acute hepatitis C
Falling through the cracks